We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Boosts Pain-Drug Pipeline, Sees Positive Alzheimer’s Data
Pfizer Boosts Pain-Drug Pipeline, Sees Positive Alzheimer’s Data
July 22, 2011
Pharma giant Pfizer is buying Icagen for $56 million, giving Pfizer a new pipeline for possible pain products.